Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
39.88
+1.07 (2.76%)
Jul 21, 2026, 3:47 PM EDT - Market open
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $4.29 billion as of July 21, 2026. Its market cap has increased by 201.23% in one year.
Market Cap
4.29B
Enterprise Value
3.77B
1-Year Change
201.23%
Ranking
Category
Stock Price
$39.88
ChartMarket Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $4.29B, an increase of 463.78%. That is a compound annual growth rate of 38.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 4.29B | 63.33% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 4.71B |
| Caris Life Sciences | 4.66B |
| Veradermics | 4.65B |
| ACADIA Pharmaceuticals | 4.38B |
| Relay Therapeutics | 4.34B |
| Celcuity | 4.31B |
| Legend Biotech | 4.31B |
| Viking Therapeutics | 4.31B |